Amplification of the neu (c-erbB-2) oncogene in human mammmary tumors is relatively frequent and is often accompanied by amplification of the linked c-erbA oncogene
- PMID: 3299059
- PMCID: PMC365313
- DOI: 10.1128/mcb.7.5.2019-2023.1987
Amplification of the neu (c-erbB-2) oncogene in human mammmary tumors is relatively frequent and is often accompanied by amplification of the linked c-erbA oncogene
Abstract
We investigated alterations in the structure and expression of oncogenes in mammary tumors and mammary tumor-derived cell lines. In 16 of 95 samples, we detected amplification of the human neu oncogene, also known as c-erB-2, accompanied by overexpression in the tumors from which intact RNA could be isolated. In 10 of these DNAs, the linked oncogene c-erbA was also amplified, whereas another gene on human chromosome 17, p53, was present in normal copy numbers. Overexpression of c-erbA could not be detected in the tumors analyzed. The relatively high frequency of neu amplification points to a functional role in human breast cancer. Coamplification of the c-erbA oncogene could contribute to this disease as well but is most likely fortuitous.
Similar articles
-
Genetic alterations of the c-erbB-2 oncogene occur frequently in tubular adenocarcinoma of the stomach and are often accompanied by amplification of the v-erbA homologue.Oncogene. 1988 Mar;2(3):283-7. Oncogene. 1988. PMID: 3281095
-
c-erbB-2/c-erbA co-amplification indicative of lymph node metastasis, and c-myc amplification of high tumour grade, in human breast carcinoma.Br J Cancer. 1989 Oct;60(4):505-10. doi: 10.1038/bjc.1989.303. Br J Cancer. 1989. PMID: 2572268 Free PMC article.
-
Correlation between c-erbB-2 amplification and risk of recurrent disease in node-negative breast cancer.Cancer Res. 1991 Jan 15;51(2):556-67. Cancer Res. 1991. PMID: 1670762
-
The neu (c-erbB-2) oncogene.Semin Oncol. 1989 Apr;16(2):148-55. Semin Oncol. 1989. PMID: 2565604 Review.
-
The significance of oncogene amplification in primary breast cancer.Int J Cancer. 1989 Feb 15;43(2):270-2. doi: 10.1002/ijc.2910430218. Int J Cancer. 1989. PMID: 2563720 Review.
Cited by
-
Genetic variation of clock genes and cancer risk: a field synopsis and meta-analysis.Oncotarget. 2017 Apr 4;8(14):23978-23995. doi: 10.18632/oncotarget.15074. Oncotarget. 2017. PMID: 28177907 Free PMC article. Review.
-
Reduced risk of breast cancer associated with recreational physical activity varies by HER2 status.Cancer Med. 2015 Jul;4(7):1122-35. doi: 10.1002/cam4.465. Epub 2015 Apr 27. Cancer Med. 2015. PMID: 25924995 Free PMC article.
-
T3 levels in relation to prognostic factors in breast cancer: a population-based prospective cohort study.BMC Cancer. 2014 Jul 24;14:536. doi: 10.1186/1471-2407-14-536. BMC Cancer. 2014. PMID: 25060772 Free PMC article.
-
Fluorescence in situ hybridization (FISH): an increasingly demanded tool for biomarker research and personalized medicine.Biomark Res. 2014 Feb 5;2(1):3. doi: 10.1186/2050-7771-2-3. Biomark Res. 2014. PMID: 24499728 Free PMC article.
-
Structure based antibody-like peptidomimetics.Pharmaceuticals (Basel). 2012 Feb 16;5(2):209-35. doi: 10.3390/ph5020209. Pharmaceuticals (Basel). 2012. PMID: 24288089 Free PMC article.
References
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical
Research Materials
Miscellaneous